Dr. Talar Kharadjian, MD

Dr. Kharadjian practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Kharadjian's NPI, 1770938201, was assigned on May 3, 2016. Dr. Kharadjian graduated from Indiana University School Of Medicine in 2016. Dr. Kharadjian holds California license A161276.

Dr. Kharadjian's primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (802) 324-1399.

Dr. Kharadjian's primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Kharadjian is also affiliated with Sharp Tri-City Medical Center. The medical group on file is Balboa Nephrology. Dmand AI also links Dr. Kharadjian to 2 more dialysis centers, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kharadjian practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Kharadjian's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Kharadjian is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Kharadjian's licenses on file in 2 states: California and Wisconsin.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease and fluid and electrolyte imbalances among the conditions Dr. Kharadjian treats.

CMS data shows 1,066 Medicare services from Dr. Kharadjian across 9 procedure codes in 2024, for 233 Medicare patients. Medicare paid $88,632 for them.

CMS counts 233 Medicare patients who saw Dr. Kharadjian in 2024. The largest group is 75 to 84, with 89 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 37% are also on Medicaid. Their average risk score is 3.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kharadjian's median patient age at 70, with 47% women.

In 2024, Dr. Kharadjian wrote 2,324 Medicare Part D claims for 249 patients. 79% of them were for generic drugs. CMS names the drug for 1,999 of them, across 51 drugs with 11 or more claims each, at $476,876 in total drug cost. In 2023, CMS named 2,228 claims across 52 drugs.

Dr. Kharadjian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kharadjian as offering telehealth.

Dmand AI links 2 papers to Dr. Kharadjian in 2020. The most frequent topics are Kidney Failure, Chronic. Dr. Kharadjian's most frequent co-authors are Abdullah Al-Asaad, MBBS, Pranav Sandilya Garimella, MD and Sarah E. Panzer, MD.

CMS Open Payments shows 38 general payments to Dr. Kharadjian from 15 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 96% of the total. AstraZeneca Pharmaceuticals LP paid the most, $340.

Dr. Kharadjian graduated from Indiana University School Of Medicine in 2016.

Dr. Kharadjian is in network with 12 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.